OpenAlex
PricingAboutJobs
Log inGet started
Work

Highly Potent and Specific GSK‐3β Inhibitors That Block Tau Phosphorylation and Decrease α‐Synuclein Protein Expression in a Cellular Model of Parkinson's Disease

HTML

Year: 2006
Type: article
Source: ChemMedChem
DOI: 10.1002/cmdc.200500039
Authors: Alan P. Kozikowski, Irina N. Gaisina, Pavel A. Petukhov, Jayalakshmi Sridhar, LaShaunda T. King, Sylvie Y. Blond, Tetyana Duka, Milan Rusnak, Anita Sidhu
Institutions: University of Illinois Chicago, Georgetown University Medical Center
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: GSK-3β inhibitors, tau phosphorylation, alpha-synuclein, Parkinson's disease, MPP+ neurotoxicity, neuronal cell death, kinase screening, small-molecule kinase inhibitors, neurodegenerative diseases
SDG: Good health and well-being

Open Access status: closed

Funders: University of Pennsylvania, National Institutes of Health, U.S. Public Health Service, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke
Awards: SYNUCLEOPATHIES IN NEURODEGENERATION, Molecular Interventions for Bipolar Disorder, G4634533325, Dopamine and Oxidative Stress in Parkinson's Disease.
OpenAlex ID: W2137617843
FWCI: 2.439
Cites: 57
Cited by: 112
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security